Kairos Pharma KAPA Q4 2025 Annual earnings
Reported March 31, 2026
EPS estimate-$0.02
Next report
Aug 11, 2026 (In 4 weeks)EPS estimate-$0.09
Versus estimates
Diluted EPS
Ask the moment Kairos Pharma reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Kairos Pharma report Q4 2025 earnings?
- Kairos Pharma (KAPA) reported Q4 2025 earnings on March 31, 2026.
- What were Kairos Pharma's Q4 2025 revenue and EPS?
- Kairos Pharma reported diluted EPS of $-0.07 for Q4 2025.
- Did Kairos Pharma beat estimates in Q4 2025?
- EPS missed the consensus estimate of $-0.02 by $0.05.
- How did Kairos Pharma's Q4 2025 results compare year-over-year?
- Compared to the same quarter a year prior, diluted EPS grew 21.3% from $-0.09.
- Where can I find Kairos Pharma's Q4 2025 SEC filings?
- You can read the 10-K periodic report (0001493152-26-014159) directly on SEC EDGAR. The filing index links above go to sec.gov.